Guidance$ELV
Elevance Health reaffirms 2026 profit forecast of at least $22.00
Elevance Health will reaffirm its 2026 earnings forecast of at least $22.00 per diluted share and its 90.2% benefit expense ratio guidance at investor meetings.
Key takeaways
- Elevance Health (ELV) expects to reaffirm its 2026 earnings forecast of at least $22.00 per diluted share at investor meetings. Adjusted earnings are expected to be at least $29.00 per diluted share, excluding about $7.00 of net unfavorable items. It also expects to reaffirm its 2026 benefit expense ratio of 90.2% plus or minus 50 basis points.
Elevance Health (ELV) expects officers to reaffirm its 2026 earnings forecast at upcoming investor and analyst meetings.
The company expects full-year 2026 earnings of at least $22.00 per diluted share, including about $7.00 per diluted share of net unfavorable items. Excluding those items, it continues to expect adjusted earnings of at least $29.00 per diluted share.
Officers will also reaffirm full-year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.